FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3,819 letters. Newest first.

  1. swedishproducts.online

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  2. A. Nelson & Co. Ltd.

    London homeopathic drug maker A. Nelson & Co. shipped children's products without microbial testing and discarded quality records.

    High risk
  3. AQ USA Inc., d.b.a Ross Healthcare Inc.

    FDA warns AQ USA/Ross Healthcare over current good manufacturing practice violations in drugs, including missing microbial testing and inadequate component and stability controls.

    High risk
  4. Dynamic Stem Cell Therapy

    FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.

    High risk
  5. ExThera Medical Corporation

    ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.

    High risk
  6. Beta Bionics, Inc.

    FDA says Beta Bionics' iLet Bionic Pancreas system had quality-system failures, including ignored complaints of severe hypoglycemia and diabetic ketoacidosis.

    High risk
  7. Tombak LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  8. East CK Trading Inc.

    East CK Trading lacked an FSVP for imported ginseng, wolfberry, and mushroom seasoning, FDA says.

    Medium
  9. MedisourceRx

    MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.

    Medium
  10. Cosmetic Manufacturers Pty Ltd.

    FDA warned Cosmetic Manufacturers Pty Ltd. that its Australian drug site was adulterated due to CGMP violations and placed its drugs on import alert.

    High risk
  11. Bertrand P. Cole, D.O.

    FDA warns Dr. Bertrand P. Cole that he gave four trial subjects too much drug by not following the study plan.

    High risk
  12. Fidelity Melon, Inc

    FDA warns Fidelity Melon for lacking foreign supplier verification for imported melons.

    Medium
  13. Elanco Animal Health USA

    FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.

    Medium
  14. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk
  15. Beach Weekend Management LLC dba Nic and Jet Fuel

    FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.

    Medium
  16. Bio-Medical Pharmaceutical Manufacturing Corporation

    Bio-Medical Pharmaceutical Manufacturing, a Houston contract manufacturer, was cited for sterile OTC drug current good manufacturing practice (CGMP) failures and drug listing violations.

    High risk
  17. Mark S. Dacey, M.D.

    FDA warns Dr. Mark S. Dacey that a trial subject underwent an optional eye-fluid sampling procedure after twice declining consent.

    High risk
  18. niqpouches.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  19. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  20. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  21. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  22. Signature Formulations, LLC

    FDA says Signature Formulations made OTC drugs on shared equipment without adequate controls, risking hormone contamination.

    High risk
  23. Boothwyn Pharmacy, LLC

    Boothwyn Pharmacy made sterile drugs in insanitary conditions and shipped lots that failed sterility and potency tests.

    High risk
  24. BNC Distribution Inc.

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  25. Maui Seafood LLC

    Maui Seafood LLC's Las Vegas RTE tuna and salmon plant had Listeria monocytogenes (a harmful bacterium) and seafood safety plan sanitation violations.

    High risk
  26. gotpouches.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  27. Cohance Lifesciences Limited

    Cohance Lifesciences, a finished-drug maker, was cited for inadequate investigations and dirty shared equipment that caused cross-contamination.

    High risk
  28. HTO Nevada, Inc. dba Kirkman

    HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.

    High risk
  29. Flextronics America LLC

    FDA warns Flextronics America, contract maker of FreeStyle Libre 3 glucose sensors in Austin, TX, over an unvalidated assembly step and weak corrective actions.

    High risk
  30. Abbott Diabetes Care, Inc.

    FDA warns Abbott Diabetes Care that FreeStyle Libre 3 glucose monitors lacked design transfer and finished-device accuracy release testing.

    High risk
  31. The Great Smart African Food LLC

    FDA says Cleveland food importer lacked required import safety plans for maize flour, peanut butter biscuits, and dried milk.

    Medium
  32. Christopher Dale Butler

    FDA warned Christopher Dale Butler that his pickled quail egg products lacked required acidified-food process controls and were deemed adulterated (unsafe under the law).

    High risk
  33. CC Pollen Company

    FDA warns CC Pollen Company of Glendale, Arizona, that its bee pollen and royal jelly supplements are adulterated and misbranded.

    High risk
  34. Unomedical Device S.A. de C.V.

    FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.

    High risk
  35. Eniva USA, Inc.

    FDA warns Eniva USA over manufacturing quality failures for Immune Support and Ashwagandha Gummies.

    Medium
  36. Carolina Seafood Inc.

    FDA warned Carolina Seafood that its ready-to-eat crab and shrimp dips had inadequate seafood hazard-control plans.

    High risk
  37. Zip Foods Importers, Inc

    Zip Foods Importers lacked required foreign supplier verification programs for many imported foods, FDA found.

    Medium
  38. Fulijaya Manufacturing SDN. BHD.

    Fulijaya Manufacturing in Malaysia failed CGMP (drug manufacturing rules) for OTC drugs, with missing lab data, flawed microbial tests, and weak stability data.

    High risk
  39. Center For Immunology Science, LLC

    FDA cites Center for Immunology Science for a clinical trial of heat-killed Mycobacterium smegmatis without an Investigational New Drug application.

    High risk
  40. Meridian Bioscience, Inc

    FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.

    High risk
  41. MAST Biosurgery USA, Inc.

    MAST Biosurgery USA never ran promised endotoxin tests on its SurgiWrap FROST surgical mesh and failed to report patient injuries, FDA says.

    High risk
  42. Asli Foods, Inc

    Asli Foods, a food importer, lacked required foreign supplier checks for chocolate, tea, and kabab mix, FDA says.

    Medium
  43. MG GROUP USA

    MG GROUP USA lacked FSVP records for imported truffle oil and fresh truffles, FDA found during an August 2025 inspection.

    Medium
  44. American Food Distributor Inc.

    FDA warns American Food Distributor for missing FSVP for imported tahina, olive oil, and mallow leaves.

    Medium
  45. Germaphobix

    FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.

    High risk
  46. Prodrome Sciences USA, LLC

    Prodrome Sciences studied its supplement ProdromeNeuro Oil as a dementia drug in 29 people without first filing an IND, FDA says.

    High risk
  47. Genetrace

    FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.

    High risk
  48. Genovate

    FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.

    High risk
  49. Integrity Partners Group

    FDA warns Integrity Partners Group about manufacturing failures at its Chemisphere drug plant, including inadequate testing, supplier verification, cleaning, and process validation.

    High risk
  50. Winder Laboratories, LLC

    FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.

    High risk